LITTLE ROCK, Ark. — The demand for new weight loss drugs like Ozempic has reached Arkansas, and a variety of healthcare businesses already feel the impact.
But a future with increased availability of GLP-1 drugs has the industry bracing for even greater change.
Bariatric surgery centers across the country are experiencing a downturn, thanks largely to the emerging class of drugs, and while that trend hasn’t yet reached bariatric clinics in Arkansas — two actually reported record years in 2023 — some doctors see a shift on the horizon.
To read more about how the rise in GLP-1 drug use is impacting Arkansas, our content partner Arkansas Business has the full article here.
Watch 5NEWS on YouTube.
Download the 5NEWS app on your smartphone:
Stream 5NEWS 24/7 on the 5+ app: How to watch the 5+ app on your streaming device
To report a typo or grammatical error, please email KFSMDigitalTeam@tegna.com and detail which story you're referring to.
